Leonardo F Jurado1, Andrés Gómez-Aldana2, Mónica Tapias3, Daniela Cáceres4, Alonso Vera5, Rocío Del Pilar López-Panqueva6, Rafael E Andrade7. 1. Departamento de Patología y Laboratorios, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia; Departamento de Patología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia; Pathology Department, McGill University, Montreal, Quebec, Canada. lfjuradoz@unal.edu.co. 2. Servicio de Trasplante Hepático, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia. andresgomezmd@hotmail.com. 3. Servicio de Trasplante Hepático, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia. monictapias@yahoo.com. 4. Servicio de Trasplante Hepático, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia. daniela23285@gmail.com. 5. Servicio de Trasplante Hepático, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia. averamd@yahoo.com. 6. Departamento de Patología y Laboratorios, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia; Facultad de Medicina, Universidad de los Andes, Bogotá, D. C., Colombia. rocilopa@gmail.com. 7. Departamento de Patología y Laboratorios, Hospital Universitario Fundación Santa Fe de Bogotá, Bogotá, D.C., Colombia; Departamento de Patología, Facultad de Medicina, Universidad Nacional de Colombia, Bogotá, D.C., Colombia; Facultad de Medicina, Universidad de los Andes, Bogotá, D. C., Colombia. rafandrade@hotmail.com.
Abstract
Introduction: The post-transplant lymphoproliferative disorders (PTLD) are characterized by an uncontrolled pathological lymphoid proliferation as a consequence of transplant immunosuppression therapy. Objective: To characterize the clinical and pathological characteristics of PTLD in a cohort of adult patients with liver transplant during a 15 year period at the Hospital Universitario Fundación Santa Fe de Bogota. Materials and methods: We conducted an observational retrospective study by searching for the PTLD cases diagnosed during the study period in the databases of the Liver Transplantation Unit and the Pathology Department. We collected the epidemiological, clinical, and pathological information and performed the corresponding statistics analyses. Results: During the research period, 572 patients were transplanted; the incidence of PTDL was 2.44%; 79% of them were man and the average age at the time of diagnosis was 62.5 years; 71% of the cases were diagnosed during the first year after the transplant and the same percentage EBV-seropositive patients. The most frequent pathological phenotype was monomorphic and the majority of tumors was detected in the hepatic hilum. The one-year survival was 50%. Conclusion: The high proportion of early cases and the high frequency of Epstein-Barr virus seropositivity both in donors and receptors drewour attention. More studies are necessary to have a better understanding of this condition in Colombia. This is the first PTLD clinical and pathological analysis in liver-transplant patients from Colombia to date.
Introduction: The post-transplant lymphoproliferative disorders (PTLD) are characterized by an uncontrolled pathological lymphoid proliferation as a consequence of transplant immunosuppression therapy. Objective: To characterize the clinical and pathological characteristics of PTLD in a cohort of adult patients with liver transplant during a 15 year period at the Hospital Universitario Fundación Santa Fe de Bogota. Materials and methods: We conducted an observational retrospective study by searching for the PTLD cases diagnosed during the study period in the databases of the Liver Transplantation Unit and the Pathology Department. We collected the epidemiological, clinical, and pathological information and performed the corresponding statistics analyses. Results: During the research period, 572 patients were transplanted; the incidence of PTDL was 2.44%; 79% of them were man and the average age at the time of diagnosis was 62.5 years; 71% of the cases were diagnosed during the first year after the transplant and the same percentage EBV-seropositive patients. The most frequent pathological phenotype was monomorphic and the majority of tumors was detected in the hepatic hilum. The one-year survival was 50%. Conclusion: The high proportion of early cases and the high frequency of Epstein-Barr virus seropositivity both in donors and receptors drewour attention. More studies are necessary to have a better understanding of this condition in Colombia. This is the first PTLD clinical and pathological analysis in liver-transplant patients from Colombia to date.
Authors: M R Luskin; D S Heil; K S Tan; S Choi; E A Stadtmauer; S J Schuster; D L Porter; R H Vonderheide; A Bagg; D F Heitjan; D E Tsai; R Reshef Journal: Am J Transplant Date: 2015-05-18 Impact factor: 8.086
Authors: T E Starzl; M A Nalesnik; K A Porter; M Ho; S Iwatsuki; B P Griffith; J T Rosenthal; T R Hakala; B W Shaw; R L Hardesty Journal: Lancet Date: 1984-03-17 Impact factor: 79.321
Authors: Jennifer Trofe; Joseph F Buell; Thomas M Beebe; Michael J Hanaway; M Roy First; Rita R Alloway; Thomas G Gross; P Succop; E Steve Woodle Journal: Am J Transplant Date: 2005-04 Impact factor: 8.086
Authors: A Kinch; L Cavelier; M Bengtsson; E Baecklund; G Enblad; C Backlin; U Thunberg; C Sundström; K Pauksens Journal: Am J Transplant Date: 2014-10-10 Impact factor: 8.086